Steroid 5α-reductase inhibitors in androgen-dependent disorders

被引：36

作者：

Harris, GS ^{[1
]}

Kozarich, JW ^{[1
]}

机构：

[1] Merck Res Labs, Dept Biochem, Rahway, NJ 07065 USA

来源：

CURRENT OPINION IN CHEMICAL BIOLOGY | 1997年 / 1卷 / 02期

关键词：

D O I：

10.1016/S1367-5931(97)80017-8

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Inhibition of the steroid 5 alpha-reductases shows promise in the treatment of a number of androgen-dependent disorders, such as benign prostatic hyperplasia, male pattern baldness, and acne, The design of potent and isozyme-selective inhibitors has provided biologists and clinicians with important tools for elucidating complex androgen physiology, and has already resulted in the development of one marketed drug. (C) Current Biology Ltd ISSN 1367-5931.

引用

收藏

页码：254 / 259

页数：6

相关论文

共 55 条

[1] A mechanism for the suppression of estrogen production in polycystic ovary syndrome [J].

Agarwal, SK ;

Judd, HL ;

Magoffin, DA .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (10) :3686-3691

[2]

AUDET P, 1993, CLIN PHARMACOL THER, V53, P231

[3]

AUDIA JE, 1996, Patent No. 5550134

[4] 4-AZA-3-OXO-5-ALPHA-ANDROST-1-ENE-17-BETA-N-ARYL-CARBOXAMIDES AS DUAL INHIBITORS OF HUMAN TYPE-1 AND TYPE-2 STEROID 5-ALPHA-REDUCTASES - DRAMATIC EFFECT OF N-ARYL SUBSTITUENTS ON TYPE-1 AND TYPE-2 5-ALPHA-REDUCTASE INHIBITORY POTENCY [J].

BAKSHI, RK ;

RASMUSSON, GH ;

PATEL, GF ;

MOSLEY, RT ;

CHANG, B ;

ELLSWORTH, K ;

HARRIS, GS ;

TOLMAN, RL .

JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (17) :3189-3192

[5] 4,7-BETA-DIMETHYL-4-AZACHOLESTAN-3-ONE (MK-386) AND RELATED 4-AZASTEROIDS AS SELECTIVE INHIBITORS OF HUMAN TYPE-1 5-ALPHA-REDUCTASE [J].

BAKSHI, RK ;

PATEL, GF ;

RASMUSSON, GH ;

BAGINSKY, WF ;

CIMIS, G ;

ELLSWORTH, K ;

CHANG, B ;

BULL, H ;

TOLMAN, RL ;

HARRIS, GS .

JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (23) :3871-3874

[6]

Bayne EK, 1997, J INVEST DERMATOL, V108, P681

[7] Mechanism-based inhibition of human steroid 5 alpha-reductase by finasteride: Enzyme-catalyzed formation of NADP-dihydrofinasteride, a potent bisubstrate analog inhibitor [J].

Bull, HG ;

GarciaCalvo, M ;

Andersson, S ;

Baginsky, WF ;

Chan, HK ;

Ellsworth, DE ;

Miller, RR ;

Stearns, RA ;

Bakshi, RK ;

Rasmusson, GH ;

Tolman, RL ;

Myers, RW ;

Kozarich, JW ;

Harris, GS .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1996, 118 (10) :2359-2365

[8] Outcome of long-term treatment with the 5 alpha-reductase inhibitor finasteride in idiopathic hirsutism: Clinical and hormonal effects during a 1-year course of therapy and 1-year follow-up [J].

Castello, R ;

Negri, C ;

Tosi, F ;

Muggeo, M ;

Perrone, F ;

Moghetti, P .

FERTILITY AND STERILITY, 1996, 66 (05) :734-740

[9] TREATMENT OF HIRSUTISM WITH THE PURE ANTIANDROGEN FLUTAMIDE [J].

CUSAN, L ;

DUPONT, A ;

BELANGER, A ;

TREMBLAY, RR ;

MANHES, G ;

LABRIE, F .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1990, 23 (03) :462-469

[10] THE EFFECT OF FINASTERIDE, A 5-ALPHA-REDUCTASE INHIBITOR, ON SCALP SKIN TESTOSTERONE AND DIHYDROTESTOSTERONE CONCENTRATIONS IN PATIENTS WITH MALE PATTERN BALDNESS [J].

DALLOB, AL ;

SADICK, NS ;

UNGER, W ;

LIPERT, S ;

GEISSLER, LA ;

GREGOIRE, SL ;

NGUYEN, HH ;

MOORE, EC ;

TANAKA, WK .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (03) :703-706

← 1 2 3 4 5 6 →